GC Therapeutics
Haydy George, MD, currently serves as Co-Founder and CEO of LabNest US since January 2023, while also acting as Chief Operating Officer Consultant for GC Therapeutics. In addition to these roles, Haydy serves as a consultant for several biotech companies, including Colossal Biosciences and 64x Bio, and has a history of consulting for various organizations, including MyTide Therapeutics and AVROBIO, Inc. Prior experience includes mentoring at Scimentorin, engaging as a research intern at the UTHSC Office of Research, and leading preclinical laboratory operations at AVROBIO. A founding member of eGenesis, Haydy managed research operations and led significant initiatives in laboratory management and efficiency, ultimately earning a nomination for the 40 Under 40 Award by the Boston Business Journal. Haydy holds a Bachelor of Science in Biology from UMass Boston.
This person is not in any teams
This person is not in any offices
GC Therapeutics
1 followers
GC Therapeutics Inc. (GCTx) uses synthetic biology to program patient-derived stem cells into any cell type with best-in-class efficiency (up to 10X), speed (up to 100X) and scalability. We dictate cells fates in a single step and have validated cells for many applications. We have also developed SuperCells™ by tailoring cells for specific diseases. The core technology of GCTx was conceived, invented and perfected in Professor George Church’s lab at Harvard Medical School. We are a group of passionate biologists and tissue engineers whose goal is to bring this breakthrough approach to patients.